Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Sep;81(2):237–241. doi: 10.1038/sj.bjc.6690683

c-Ki-ras mutations in colorectal adenocarcinomas from a country with a rapidly changing colorectal cancer incidence

W-Y Tang 1, J Elnatan 1, Y-S Lee 2, H-S Goh 1, D R Smith 1
PMCID: PMC2362864  PMID: 10496348

Abstract

We have examined the incidence of mutation of the c-Ki-ras proto-oncogene in colorectal adenocarcinomas from two different time periods, namely 1962–1966 and 1994–1996. The first cohort of samples consisted of formalin-fixed, archival paraffin block and represent the oldest colorectal cancer samples for which ras mutation has been examined, while the second cohort of tumours were fresh, flash-frozen samples representative of genetic events occurring in contemporary times. Analysis of mutation status was undertaken by a mismatch-specific oligonucleotide hybridization analysis of exon 1 of the c-Ki-ras proto-oncogene after amplification by the polymerase chain reaction. Mutations in codon 12 or 13 of c-Ki-ras were detected in 28% (14/50) of contemporary samples, a figure consistent with locally established mutation rates. In contrast no mutation was detected in any of the 18 samples from the earlier period, a result that is statistically significant (P = 0.007). Age-standardized rates of colorectal cancer in Singapore have seen a marked increase over the last 30 years, and for the first time we have shown that such an increase in colorectal cancer is associated, at least in part with an increase in incidence of a specific mutagenic change. © 1999 Cancer Research Campaign

Keywords: colon cancer, ras, proto-oncogene, mutation

Full Text

The Full Text of this article is available as a PDF (102.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baba S. Recent advances in molecular genetics of colorectal cancer. World J Surg. 1997 Sep;21(7):678–687. doi: 10.1007/s002689900291. [DOI] [PubMed] [Google Scholar]
  2. Barbacid M. ras genes. Annu Rev Biochem. 1987;56:779–827. doi: 10.1146/annurev.bi.56.070187.004023. [DOI] [PubMed] [Google Scholar]
  3. Bos J. L., Fearon E. R., Hamilton S. R., Verlaan-de Vries M., van Boom J. H., van der Eb A. J., Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. 1987 May 28-Jun 3Nature. 327(6120):293–297. doi: 10.1038/327293a0. [DOI] [PubMed] [Google Scholar]
  4. Bos J. L. ras oncogenes in human cancer: a review. Cancer Res. 1989 Sep 1;49(17):4682–4689. [PubMed] [Google Scholar]
  5. Breivik J., Meling G. I., Spurkland A., Rognum T. O., Gaudernack G. K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br J Cancer. 1994 Feb;69(2):367–371. doi: 10.1038/bjc.1994.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chaplin M. F. Bile acids, fibre and colon cancer: the story unfolds. J R Soc Health. 1998 Feb;118(1):53–61. doi: 10.1177/146642409811800111. [DOI] [PubMed] [Google Scholar]
  7. Colditz G. A., Branch L. G., Lipnick R. J., Willett W. C., Rosner B., Posner B. M., Hennekens C. H. Increased green and yellow vegetable intake and lowered cancer deaths in an elderly population. Am J Clin Nutr. 1985 Jan;41(1):32–36. doi: 10.1093/ajcn/41.1.32. [DOI] [PubMed] [Google Scholar]
  8. Elnatan J., Goh H. S., Smith D. R. C-KI-RAS activation and the biological behaviour of proximal and distal colonic adenocarcinomas. Eur J Cancer. 1996 Mar;32A(3):491–497. doi: 10.1016/0959-8049(95)00567-6. [DOI] [PubMed] [Google Scholar]
  9. Fearon E. R., Jones P. A. Progressing toward a molecular description of colorectal cancer development. FASEB J. 1992 Jul;6(10):2783–2790. doi: 10.1096/fasebj.6.10.1321771. [DOI] [PubMed] [Google Scholar]
  10. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  11. Finkelstein S. D., Sayegh R., Bakker A., Swalsky P. Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg. 1993 May;128(5):526–532. doi: 10.1001/archsurg.1993.01420170056008. [DOI] [PubMed] [Google Scholar]
  12. Finkelstein S. D., Sayegh R., Christensen S., Swalsky P. A. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer. 1993 Jun 15;71(12):3827–3838. doi: 10.1002/1097-0142(19930615)71:12<3827::aid-cncr2820711207>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  13. Goh H. S., Yao J., Smith D. R. p53 point mutation and survival in colorectal cancer patients. Cancer Res. 1995 Nov 15;55(22):5217–5221. [PubMed] [Google Scholar]
  14. Gourley L., Duffy S. W., Lee H. P., Walker A. M., Day N. E. A survey of household food purchases and dietary habits in relation to affluence among Singapore Chinese. Eur J Clin Nutr. 1988 Apr;42(4):333–343. [PubMed] [Google Scholar]
  15. Graham S., Dayal H., Swanson M., Mittelman A., Wilkinson G. Diet in the epidemiology of cancer of the colon and rectum. J Natl Cancer Inst. 1978 Sep;61(3):709–714. [PubMed] [Google Scholar]
  16. Grand R. J., Owen D. The biochemistry of ras p21. Biochem J. 1991 Nov 1;279(Pt 3):609–631. doi: 10.1042/bj2790609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Haenszel W., Berg J. W., Segi M., Kurihara M., Locke F. B. Large-bowel cancer in Hawaiian Japanese. J Natl Cancer Inst. 1973 Dec;51(6):1765–1779. doi: 10.1093/jnci/51.6.1765. [DOI] [PubMed] [Google Scholar]
  18. Haenszel W., Locke F. B., Segi M. A case-control study of large bowel cancer in Japan. J Natl Cancer Inst. 1980 Jan;64(1):17–22. [PubMed] [Google Scholar]
  19. Hua V. Y., Wang W. K., Duesberg P. H. Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers. Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9614–9619. doi: 10.1073/pnas.94.18.9614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jen J., Powell S. M., Papadopoulos N., Smith K. J., Hamilton S. R., Vogelstein B., Kinzler K. W. Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 1994 Nov 1;54(21):5523–5526. [PubMed] [Google Scholar]
  21. Keohavong P., Zhu D., Whiteside T. L., Swalsky P., Bakker A., Elder E. M., Siegfried J. M., Srivastava S., Finkelstein S. D. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues. Anal Biochem. 1997 May 1;247(2):394–403. doi: 10.1006/abio.1997.2100. [DOI] [PubMed] [Google Scholar]
  22. Khine K., Smith D. R., Goh H. S. High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer. Cancer. 1994 Jan 1;73(1):28–35. doi: 10.1002/1097-0142(19940101)73:1<28::aid-cncr2820730107>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  23. La Vecchia C., Negri E., Decarli A., D'Avanzo B., Gallotti L., Gentile A., Franceschi S. A case-control study of diet and colo-rectal cancer in northern Italy. Int J Cancer. 1988 Apr 15;41(4):492–498. doi: 10.1002/ijc.2910410404. [DOI] [PubMed] [Google Scholar]
  24. Lee H. P., Gourley L., Duffy S. W., Estève J., Lee J., Day N. E. Colorectal cancer and diet in an Asian population--a case-control study among Singapore Chinese. Int J Cancer. 1989 Jun 15;43(6):1007–1016. doi: 10.1002/ijc.2910430609. [DOI] [PubMed] [Google Scholar]
  25. Lee H. P., Gourley L. Fat and fibre in the Singapore diet. Ann Acad Med Singapore. 1987 Jul;16(3):408–411. [PubMed] [Google Scholar]
  26. Manousos O., Day N. E., Trichopoulos D., Gerovassilis F., Tzonou A., Polychronopoulou A. Diet and colorectal cancer: a case-control study in Greece. Int J Cancer. 1983 Jul 15;32(1):1–5. doi: 10.1002/ijc.2910320102. [DOI] [PubMed] [Google Scholar]
  27. Otori K., Sugiyama K., Hasebe T., Fukushima S., Esumi H. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. Cancer Res. 1995 Nov 1;55(21):4743–4746. [PubMed] [Google Scholar]
  28. Tachino N., Hayashi R., Liew C., Bailey G., Dashwood R. Evidence for ras gene mutation in 2-amino-3-methylimidazo[4,5-f]quinoline-induced colonic aberrant crypts in the rat. Mol Carcinog. 1995 Apr;12(4):187–192. doi: 10.1002/mc.2940120402. [DOI] [PubMed] [Google Scholar]
  29. Verlaan-de Vries M., Bogaard M. E., van den Elst H., van Boom J. H., van der Eb A. J., Bos J. L. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene. 1986;50(1-3):313–320. doi: 10.1016/0378-1119(86)90335-5. [DOI] [PubMed] [Google Scholar]
  30. Vogelstein B., Fearon E. R., Hamilton S. R., Kern S. E., Preisinger A. C., Leppert M., Nakamura Y., White R., Smits A. M., Bos J. L. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988 Sep 1;319(9):525–532. doi: 10.1056/NEJM198809013190901. [DOI] [PubMed] [Google Scholar]
  31. Yamashita N., Minamoto T., Ochiai A., Onda M., Esumi H. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology. 1995 Feb;108(2):434–440. doi: 10.1016/0016-5085(95)90071-3. [DOI] [PubMed] [Google Scholar]
  32. Yamashita N., Minamoto T., Ochiai A., Onda M., Esumi H. Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression? Cancer. 1995 Mar 15;75(6 Suppl):1527–1533. doi: 10.1002/1097-0142(19950315)75:6+<1527::aid-cncr2820751524>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  33. Yanez L., Groffen J., Valenzuela D. M. c-K-ras mutations in human carcinomas occur preferentially in codon 12. Oncogene. 1987;1(3):315–318. [PubMed] [Google Scholar]
  34. Zhu D., Keohavong P., Finkelstein S. D., Swalsky P., Bakker A., Weissfeld J., Srivastava S., Whiteside T. L. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Cancer Res. 1997 Jun 15;57(12):2485–2492. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES